Global Injectable Drug Delivery Technology Market for Therapeutics Growth, Trends and Forecasts 2017 - 2022

  • ID: 4388031
  • Report
  • Region: Global
  • 197 pages
  • Mordor Intelligence
1 of 4
The Global Injectable Drug Delivery Market is estimated to be USD 40.5 billion for the year 2015. The market is expected to grow with a CAGR of about 18.1% during the forecasted period and is expected to reach USD92.65 billion by the end of 2020.

Injectable allow the transport of drugs formulated in liquid form and facilitates the rapid transport of a drug into the body. It also helps in administering drugs in unconscious and comatose patients. These delivery systems are highly accepted due to their advantage of faster onset of action with high efficacy. Also in the recent years this market has increased due to increasing prevalence of cancer and diabetes.

Increased prevalence of chronic diseases, increased patient compliance, technological advances in the form of nanotechnologies and rising demand for biologics in the pharmaceutical industry are the major factors driving the market growth. Possibility of injuries and infections via usage, product recalls, emergence of alternative drug delivery systems and regulatory framework concerns are the major challenges faced by Global Injectable Drug Delivery Market.

The Market is basically segmented by basis of devices, by application, by mode of administration, by end users and by geography. Based on formulation the market is segmented into two categories; Conventional Drug Delivery and Novel Drug Delivery. On the basis of devices, the market is segmented into Conventional devices and Self-injectable devices. The injectable drug delivery devices technologies market is further categorized into conventional injection devices, self-injection devices, and others (micro needles, nano needles and blunt needle injections). The market analysis is also provided for different geographical areas which include North America, Europe, APAC, Middle East and Africa and Latin America.

The major players in this market are Alkermes, Genetech, Bend Research, QLT Inc, Endocyte, Crossjet, Apogee Technology, Pulmatrix, Medicago, Liquida Technologies Inc, UCB Group, Pearl Therpeutics, Antares Pharmaceuticals Ltd, Baxter International, Becton Dickinson Company, Elcam Medical, Eli Lily and Company, Unilife Corporation and West Pharmaceutical Inc.

Key Deliverables in the Study

Market analysis for the Global Injectable Drug Delivery Market, with region specific assessments and competition analysis on global and regional scales

Market definition along with the identification of key drivers and restraints

Identification of factors instrumental in changing the market scenarios, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale

Extensively researched competitive landscape section with profiles of major companies along with their market shares

Identification and analysis of the macro and micro factors that affect the global Injectable Drug Delivery market on both global and regional scales

A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information

A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market

Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
READ MORE
Note: Product cover images may vary from those shown
2 of 4
1.INTRODUCTION
1.1 Report Description
1.2 Research Methodology
1.3 Stakeholders
2. EXECUTIVE SUMMARY
2.1 Key Findings
2.2 Market Overview
3. MARKET OVERVIEW
3.1 Market Defenition
3.1.1 Introduction
3.1.2 Modes of Injectable Drug Delivery systems
3.2 Market Drivers
3.2.1 Inreasing prevelance of Chronic Diseases
3.2.2 Increased Demand
3.2.3 Technological Advances
3.3 Market Limitations
3.3.1 Injuries and Infections
3.3.2 Recent Advancements
3.3.3 Regulatory Framework
3.4 Market Challenges
3.4.1 Sustainability
3.5 Market Opportunities
3.5.1 Emerging Countries
4. Global Injectables Drug Delivey Technology Market Segmentation
4.1 Types
4.2 Devices
4.3 Application
4.4 Geography
5. Global Injectables Drug Delivey Technology Market by Applications
5.1 Cardiovascular Diseases
5.2 Diabetes
5.3 Regenerative Medicine
5.4 Oncology
5.5 Pain Management
5.6 Hepatitis C
5.7 Auto Immune Disorders
6. GLOBAL MARKETS: SEGMENTATION BY GEOGRAPHY
6.1 North America
6.1.1 US
6.1.2 Canada
6.2 Europe
6.2.1 UK
6.2.2 Germany
6.2.3 France
6.3 APAC
6.3.1 India
6.3.2 China
6.3.3 South Korea
6.3.4 Japan
6.4 Rest of the World
6.4.1 Brazil
6.4.2 Middle East
6.4.3 Australia
7. Competitive Landscape
7.1 Introduction
7.2 Mergers & Acquisitions
7.3 Expansions
7.4 New Product Launch
7.5Collaborations
8. Top Company Profiles
Alkermes Inc.
Genentech Inc.
Bend Research
QLT Inc.
Endocyte
BIND Biosciences, Inc.
UCB Group (UCB)
Presage Bioscience
Polymer Factory
MicroCHIPS, Inc.
Pearl Therapeutics Inc.
Piedmont Pharmaceuticals
Zogenix, Inc.
Liquidia Technologies
Impax Laboratories Inc.
Boehringer Ingelheim
Crossject Medical Technology
Apogee Technology
Pulmatrix
Medicago
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll